Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.
URL: http://www.news-medical.net/news/20120821/Molecular-Partners-Allergan-to-develop-and-commercialize-DARPins-against-ophthalmic-diseases.aspx
No comments:
Post a Comment